Background: Even if type A behavior pattern is not a typical pattern of specific social class, in Italy no research study has been conducted on blue-collar workers. In the present study we sought to identify differences in the psychological profiles of type A and non-type A Italian blue-collar subjects. Methods: Seventy-three healthy male blue-collar workers, aged 35-59 years, completed the CBA-2.0 Primary Scales (a battery of standardized questionnaires) and the Jenkins Activity Survey (JAS). Following the Structured Interview each subject was classified as type A1 A2, X, or B. In the present study, type X and B subjects were considered within the group referred to as type ‘non-A’. Results: The analysis of variance showed that the A1 subjects had higher neuroticism scores than the A2 and non-A subjects but revealed no differences in extraversion, anxiety, depression, obsession-compulsion scores. In the JAS only the ‘speed and impatience’ scale differentiated the three groups: the highest scores being obtained by the A1 subjects. Among the JAS scales, only correlations (Pearson) between speed and impatience, trait anxiety and neuroticism were found. Conclusion: In our Italian blue-collar sample, type A1 seems to define a subject with high neuroticism score. Finally, our results do not recommend the use of the JAS in Italy for measuring the type A behavior pattern.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.